Spyryx Biosciences
Latest round
- Series A
Last raised
- Apr 2015
Total raised
- $18M
Investors
- 3
About Spyryx Biosciences
Spyryx Biosciences is dedicated to developing innovative therapeutics for obstructive lung diseases like Cystic Fibrosis and COPD.Founded in 2013 in Durham, US, Spyryx Biosciences focuses on creating therapies for lung diseases.Spyryx Biosciences specializes in developing innovative therapeutics for obstructive lung diseases, primarily targeting Cystic Fibrosis (CF) and Chronic Obstructive Pulmonary Disease (COPD). Their lead investigational product, SPX-101, is an inhaled peptide designed to enhance mucociliary clearance by targeting epithelial sodium channels (ENaC), addressing dehydration-induced lung disease.Spyryx Biosciences generates revenue through the clinical development and commercialization of its therapeutic products, mainly SPX-101. As clinical trials advance, potential revenue may derive from partnerships with healthcare institutions and agreements with pharmaceutical distributors. The company aims to expand its reach into new geographical markets, focusing on regions such as Canada and Europe by the end of 2021. Additionally, Spyryx is exploring the development of new products that align with their mission to treat obstructive lung diseases, ensuring a strategic approach to growth.
Who invested in Spyryx Biosciences
3 investors across 1 round
See all investors in Spyryx Biosciences
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Apr 24, 2015
Amount
$18M
Investors
Questions about Spyryx Biosciences
Who invested in Spyryx Biosciences?
Spyryx Biosciences has 3 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Spyryx Biosciences raised?
Spyryx Biosciences has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Spyryx Biosciences last raise money?
Spyryx Biosciences's most recent round on record is a Series A, in Apr 2015.
What does Spyryx Biosciences do?
Spyryx Biosciences is dedicated to developing innovative therapeutics for obstructive lung diseases like Cystic Fibrosis and COPD.
Where is Spyryx Biosciences headquartered?
Spyryx Biosciences is headquartered in Durham, US.
Which VCs invest in companies like Spyryx Biosciences?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at Spyryx Biosciences's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series A
Raising like Spyryx Biosciences? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.